Healthtech company adds key clinical expertise as it moves closer to commercialization of its next-generation blood testing ecosystem AUSTIN, Texas–(BUSINESS WIRE)–#BloodTesting–Babson Diagnostics, a science-first health care technology company, today announced the addition of a clinical advisor who will bring valuable insights of the medical community in the ongoing development and introduction of the company’s new … [Read more…]

Researchers highlight the importance of next-generation technologies as strategic tools for drug discovery WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting, with 19 scientific posters and a spotlight presentation to highlight its enhanced oncology … [Read more…]

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a private drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, today announced that Theodore Liston, Ph.D., Vice President of Research at Astrocyte, received the 2022 Progress and Innovation Award from the journal Stroke for authoring one of the journal’s top three publications in 2022. … [Read more…]

– Putative therapeutic 5-HTP plasma exposures were achieved at all dose levels evaluated – Pharmacodynamic biomarker data demonstrated target engagement, indicative of brain extracellular serotonin elevation beyond the first-line antidepressant effect – The dose range was determined for the planned Phase 2 trial in Major Depressive Disorder patients inadequately responding to first-line antidepressant therapy RESEARCH … [Read more…]

The Pivotal Study is Aimed to Support a Marketing Authorization Application PETACH TIKVA, Israel,–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that it received a positive opinion from the Committee for Medicinal Products for … [Read more…]

Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics. Aviceda Executives will participate in a Cancer Showcase Event as part of the 25th Anniversary of the Good Friday Agreement … [Read more…]

Recognition Honors Athletic Trainers for their Dedication Toward Advancing the Athletic Training Profession, While Keeping Athletes in the Game MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), announced Gina Harris, Head Athletic Trainer at Bellport High School in Brookhaven, New York, as the winner of the third annual … [Read more…]

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to report first quarter 2023 financial results after the close of trading on Monday, May 1. Axonics will host a conference call at 4:30 p.m. Eastern Time … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis Report By Services (Quality Assurance, Contract Manufacturing), By Application (Cardiology, Diagnostic Imaging, IVD), By Class, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. medical device outsourcing market size is expected to reach USD 58.5 billion by … [Read more…]